HISTOLAB PRODUCTS AS
Operating
Histolab | Histolab
Histolab Products AB är den ledande leverantören av helhetslösningar till forsknings- och kliniska laboratorier inom celldiagnostik i Norden.
Salg av førbrukningsartikler, kemikalier og instrument til
laboratorier og andre produkter som naturlig faller sammen med dette,
herunder å delta i andre selskaper med lignende virksomhet, kjøp og
salg av aksjer, eller på annen måte gjøre seg interessert i andre
foretagender.
Links
Organization
- CEO
- Chairman of the board
- Years since formation
- 16 years
- since Apr 19, 2010
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 100
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Total operating income 2024
- 32,467,429
- NOK
- Annual total result 2024
- 206,566
- NOK
- Total equity 2024
- 3,473,350
- NOK
Last update: Feb 13, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
| Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
| Chairman | - | |
| Board Member | - | |
FB | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - |
Last update: Nov 21, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 100 | 100 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 32,467,429 | 37,353,088 | 21,143,476 | 24,031,207 |
Annual Total Result | 206,566 | 220,071 | 152,176 | 142,116 |
Total assets | 10,411,742 | 6,522,586 | 8,676,749 | 5,482,648 |
Total liabilities | 6,938,393 | 3,255,802 | 5,628,999 | 2,587,073 |
Total equity | 3,473,350 | 3,266,784 | 3,047,751 | 2,895,574 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 32,467,429 | 37,353,088 | 21,143,476 | 24,031,207 |
Total operating costs | 32,387,594 | 37,162,178 | 20,947,653 | 23,849,140 |
Operating result | 79,835 | 190,910 | 195,823 | 182,067 |
Financial income/costs | 186,701 | 95,626 | -1,849 | 333 |
Profit before tax | 266,536 | 286,536 | 193,973 | 182,400 |
Total tax & extraordinary income/cost | 59,970 | 66,465 | 41,797 | 40,284 |
Annual Total Result | 206,566 | 220,071 | 152,176 | 142,116 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 17,600 | 27,500 | 0 | 0 |
Total current assets | 10,394,142 | 6,495,086 | 8,676,749 | 5,482,648 |
Total assets | 10,411,742 | 6,522,586 | 8,676,749 | 5,482,648 |
Short term debt | 6,938,393 | 3,255,802 | 5,628,999 | 2,587,073 |
Long term debt | 0 | 0 | 0 | 0 |
Total liabilities | 6,938,393 | 3,255,802 | 5,628,999 | 2,587,073 |
Contributed capital | 100,000 | 100,000 | 100,000 | 100,000 |
Retained earnings | 3,373,350 | 3,166,784 | 2,947,751 | 2,795,574 |
Total equity | 3,473,350 | 3,266,784 | 3,047,751 | 2,895,574 |
Total equity and liabilities | 10,411,743 | 6,522,586 | 8,676,749 | 5,482,648 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises